2-Me-DET

Chemical compound
title: "2-Me-DET" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["2-alkyltryptamines", "n,n-dialkyltryptamines", "diethylamino-compounds", "psychedelic-tryptamines", "tihkal"] description: "Chemical compound" topic_path: "general/2-alkyltryptamines" source: "https://en.wikipedia.org/wiki/2-Me-DET" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
::summary Chemical compound ::
::data[format=table title="Infobox drug"]
| Field | Value |
|---|---|
| image | 2-Me-DET structure.svg |
| image_class | skin-invert-image |
| width | 225px |
| image2 | 2-Me-DET 3D.png |
| image_class2 | bg-transparent |
| width2 | 200px |
| routes_of_administration | Oral |
| class | Psychoactive drug; Serotonergic psychedelic; Hallucinogen |
| ATC_prefix | None |
| duration_of_action | 6–8 hours |
| CAS_number | 26628-88-6 |
| UNII_Ref | |
| UNII | SSF4F77CV3 |
| PubChem | 33561 |
| ChemSpiderID | 30962 |
| synonyms | 2-Methyl-DET; 2-Methyl-N,N-diethyltryptamine |
| IUPAC_name | N,N-diethyl-2-(2-methyl-1H-indol-3-yl)ethanamine |
| C | 15 |
| SMILES | CCN(CC)CCc1c(C)[nH]c2ccccc12 |
| StdInChI | 1S/C15H22N2/c1-4-17(5-2)11-10-13-12(3)16-15-9-7-6-8-14(13)15/h6-9,16H,4-5,10-11H2,1-3H3 |
| StdInChIKey | VVUATPWGKMGHGM-UHFFFAOYSA-N |
| :: |
| drug_name = | image = 2-Me-DET structure.svg | image_class = skin-invert-image | width = 225px | image2 = 2-Me-DET 3D.png | image_class2 = bg-transparent | width2 = 200px
| pronounce = | tradename = | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = | licence_US = | pregnancy_AU = | pregnancy_category = | dependency_liability = | addiction_liability = | routes_of_administration = Oral | class = Psychoactive drug; Serotonergic psychedelic; Hallucinogen | ATC_prefix = None | ATC_suffix =
| legal_status =
| bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = | duration_of_action = 6–8 hours | excretion =
| CAS_number = 26628-88-6 | CAS_supplemental = | UNII_Ref = | UNII = SSF4F77CV3 | PubChem = 33561 | IUPHAR_ligand = | DrugBank = | ChemSpiderID = 30962 | KEGG = | ChEBI = | ChEMBL = | NIAID_ChemDB = | PDB_ligand = | synonyms = 2-Methyl-DET; 2-Methyl-N,N-diethyltryptamine
| IUPAC_name = N,N-diethyl-2-(2-methyl-1H-indol-3-yl)ethanamine | C=15 | H=22 | N=2 | SMILES = CCN(CC)CCc1c(C)[nH]c2ccccc12 | StdInChI = 1S/C15H22N2/c1-4-17(5-2)11-10-13-12(3)16-15-9-7-6-8-14(13)15/h6-9,16H,4-5,10-11H2,1-3H3 | StdInChIKey = VVUATPWGKMGHGM-UHFFFAOYSA-N
2-Me-DET, or 2-methyl-DET, also known as 2-methyl-N,N-diethyltryptamine, is a psychedelic drug of the tryptamine family. It is the 2-methyl derivative of diethyltryptamine (DET). The drug is taken orally.
Use and effects
In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists 2-Me-DET's dose as 80 to 120mg orally and its duration as 6 to 8hours. The effects of 2-Me-DET have been reported to include a vague unreal feeling, clouding and slowing of thoughts, DiPT-like sound distortion including higher pitches of music sounding muffled and tones shifting to a lower frequency, and stomach ache.
Interactions
Chemistry
Synthesis
The chemical synthesis of 2-Me-DET has been described.
Analogues
Analogues of 2-Me-DET include 2-methyltryptamine (2-MT; 2-Me-T), 2-methyl-DMT (2-Me-DMT; 2,N,N-TMT), 2-methyl-5-MeO-DMT (5-MeO-2,N,N-TMT), and 2-methyl-AMT (2-Me-AMT; 2,α-DMT).
History
2-Me-DET was first described in the scientific literature by R. B. Barlow and I. Khan in 1959. Subsequently, it was described in greater detail by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved).
References
References
- {{CiteTiHKAL
- (March 1959). "Actions of some analogues of tryptamine on the isolated rat uterus and on the isolated rat fundus strip preparations". Br J Pharmacol Chemother.
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::